Orange Book product · Brand (NDA)
XIFYRM
MELOXICAM
At a glance
Jun 05, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 05, 2025
1 yr 1 mo ago
Today
Patent 12263176 expires
Listed drug product patent expiration.
Jul 31, 2041
in 15 yr 4 mo
Pharmaceutical detail
Active ingredient
MELOXICAM
Strength
30MG/ML (30MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 218395
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025QAMZOVABrand (NDA)
NDA 217593 · NANJING DELOVA
- 2020ANJESOBrand (NDA)
NDA 210583 · BAUDAX
- 2018QMIIZ ODTBrand (NDA)
NDA 211210 · TERSERA
- 2015VIVLODEXBrand (NDA)
NDA 207233 · ICEUTICA OPERATIONS
- 2004MELOXICAMBrand (NDA)
NDA 021530 · AVONDALE PHARMS
- 2000MOBICBrand (NDA)
NDA 020938 · BOEHRINGER INGELHEIM
- 2023MELOXICAMGeneric (ANDA)
ANDA 217579 · ASCENT PHARMS INC
- 2021MELOXICAMGeneric (ANDA)
ANDA 211398 · NOVITIUM PHARMA
- 2020MELOXICAMGeneric (ANDA)
ANDA 209487 · LUPIN
- 2009MELOXICAMGeneric (ANDA)
ANDA 077928 · NOVITIUM PHARMA
- 2006MELOXICAMGeneric (ANDA)
ANDA 077927 · UNICHEM
- 2006MELOXICAMGeneric (ANDA)
ANDA 078039 · CR DOUBLE CRANE
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12263176 | Jul 31, 2041 | in 15 yr 4 mo | Product |

